KTN's online platform helps you to make the connections you need


The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.


The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

£250,000 investment for vaccine research firm

A bio firm, which discovers and develops vaccines to prevent bacterial infections, has received a £250,000 funding boost.

Absynth Biologics received the investment from Alderley Park Ventures, the £5m investment fund created in late 2014 and managed by BioCity, to invest in life science companies based at BioHub on the Alderley Park site in Cheshire.

Absynth Biologics, a University of Sheffield spinout firm, was founded in 2007 and has established a vaccine pipeline with two main programmes, which includes tackling staph infection and MRSA.

As a “cornerstone” tenant at BioHub, Absynth Biologics is the second company to receive funding from APV, following the £200,000 investment into Alderley Analytical in August.

Absynth Biologics will use the latest round of investment to develop further R&D while supporting its existing research.

Read the full Manchester Evening News Article here